<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000046664">
  <TermName>anhydrovinblastine</TermName>
  <TermPronunciation>(an-HY-droh-vin-BLAS-teen)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>An anticancer drug that belongs to the family of drugs called mitotic inhibitors.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000731707" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anhydrovinblastine&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000731706" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;anhidrovinblastina&quot;" language="es" id="_4"/>
  <SpanishTermName>anhidrovinblastina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento contra el cáncer que es un tipo de inhibidor mitótico.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
</GlossaryTerm>
